These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28219770)

  • 1. Silencing of the mRNA-binding protein HuR increases the sensitivity of colorectal cancer cells to ionizing radiation through upregulation of caspase-2.
    Badawi A; Hehlgans S; Pfeilschifter J; Rödel F; Eberhardt W
    Cancer Lett; 2017 May; 393():103-112. PubMed ID: 28219770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of the ELAV1-like protein HuR sensitizes adenocarcinoma cells to the intrinsic apoptotic pathway by increasing the translation of caspase-2L.
    Winkler C; Doller A; Imre G; Badawi A; Schmid T; Schulz S; Steinmeyer N; Pfeilschifter J; Rajalingam K; Eberhardt W
    Cell Death Dis; 2014 Jul; 5(7):e1321. PubMed ID: 25010987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Caspase-2 Translation by the mRNA Binding Protein HuR: A Novel Path of Therapy Resistance in Colon Carcinoma Cells?
    Eberhardt W; Nasrullah U; Haeussler K
    Cells; 2019 Jul; 8(8):. PubMed ID: 31366165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy.
    Mehta M; Basalingappa K; Griffith JN; Andrade D; Babu A; Amreddy N; Muralidharan R; Gorospe M; Herman T; Ding WQ; Ramesh R; Munshi A
    Oncotarget; 2016 Oct; 7(40):64820-64835. PubMed ID: 27588488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of TRIM25 as a Negative Regulator of Caspase-2 Expression Reveals a Novel Target for Sensitizing Colon Carcinoma Cells to Intrinsic Apoptosis.
    Nasrullah U; Haeussler K; Biyanee A; Wittig I; Pfeilschifter J; Eberhardt W
    Cells; 2019 Dec; 8(12):. PubMed ID: 31842382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SMAC mimetic BV6 sensitizes colorectal cancer cells to ionizing radiation by interfering with DNA repair processes and enhancing apoptosis.
    Hehlgans S; Oppermann J; Reichert S; Fulda S; Rödel C; Rödel F
    Radiat Oncol; 2015 Sep; 10():198. PubMed ID: 26383618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
    Lin GL; Ting HJ; Tseng TC; Juang V; Lo YL
    PLoS One; 2017; 12(10):e0185625. PubMed ID: 28968471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttranscriptional Regulation of
    Chand SN; Zarei M; Schiewer MJ; Kamath AR; Romeo C; Lal S; Cozzitorto JA; Nevler A; Scolaro L; Londin E; Jiang W; Meisner-Kober N; Pishvaian MJ; Knudsen KE; Yeo CJ; Pascal JM; Winter JM; Brody JR
    Cancer Res; 2017 Sep; 77(18):5011-5025. PubMed ID: 28687616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HuR mediated post-transcriptional regulation as a new potential adjuvant therapeutic target in chemotherapy for pancreatic cancer.
    Jakstaite A; Maziukiene A; Silkuniene G; Kmieliute K; Gulbinas A; Dambrauskas Z
    World J Gastroenterol; 2015 Dec; 21(46):13004-19. PubMed ID: 26675757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K).
    Eder S; Arndt A; Lamkowski A; Daskalaki W; Rump A; Priller M; Genze F; Wardelmann E; Port M; Steinestel K
    Cancer Lett; 2017 Jan; 385():160-167. PubMed ID: 27793696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of IRES-dependent translation of caspase-2 by HuR confers chemotherapeutic drug resistance in colon carcinoma cells.
    Badawi A; Biyanee A; Nasrullah U; Winslow S; Schmid T; Pfeilschifter J; Eberhardt W
    Oncotarget; 2018 Apr; 9(26):18367-18385. PubMed ID: 29719611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic overexpression of RNA-binding protein HuR is a marker of poor prognosis in meningioma, and HuR knockdown decreases meningioma cell growth and resistance to hypoxia.
    Gauchotte G; Hergalant S; Vigouroux C; Casse JM; Houlgatte R; Kaoma T; Helle D; Brochin L; Rech F; Peyre M; Labrousse F; Vallar L; Guéant JL; Vignaud JM; Battaglia-Hsu SF
    J Pathol; 2017 Aug; 242(4):421-434. PubMed ID: 28493484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer.
    Zhu H; Berkova Z; Mathur R; Sehgal L; Khashab T; Tao RH; Ao X; Feng L; Sabichi AL; Blechacz B; Rashid A; Samaniego F
    Mol Cancer Res; 2015 May; 13(5):809-18. PubMed ID: 25678597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RNA-Binding Protein HuR Confers Oxaliplatin Resistance of Colorectal Cancer By Upregulating CDC6.
    Cai J; Wang H; Jiao X; Huang R; Qin Q; Zhang J; Chen H; Feng D; Tian X; Wang H
    Mol Cancer Ther; 2019 Jul; 18(7):1243-1254. PubMed ID: 31064870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells.
    Muralidharan R; Mehta M; Ahmed R; Roy S; Xu L; Aubé J; Chen A; Zhao YD; Herman T; Ramesh R; Munshi A
    Sci Rep; 2017 Aug; 7(1):9694. PubMed ID: 28855578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttranscriptional Regulation of Human Antigen R by miR-133b Enhances Docetaxel Cytotoxicity Through the Inhibition of ATP-Binding Cassette Subfamily G Member 2 in Prostate Cancer Cells.
    Liu H; Song X; Hou J; Zhao Z; Chang J
    DNA Cell Biol; 2018 Mar; 37(3):210-219. PubMed ID: 29327946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between C2ORF68 and HuR in human colorectal cancer.
    Lv Z; He K; Shi L; Shi K; Jiang T; Chen Y
    Oncol Rep; 2019 Mar; 41(3):1918-1928. PubMed ID: 30664176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-155-5p controls colon cancer cell migration via post-transcriptional regulation of Human Antigen R (HuR).
    Al-Haidari A; Algaber A; Madhi R; Syk I; Thorlacius H
    Cancer Lett; 2018 May; 421():145-151. PubMed ID: 29471005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
    To KK; Leung WW; Ng SS
    Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer.
    Rödel F; Hoffmann J; Distel L; Herrmann M; Noisternig T; Papadopoulos T; Sauer R; Rödel C
    Cancer Res; 2005 Jun; 65(11):4881-7. PubMed ID: 15930309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.